Title: Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
Journal: Circulation 20161101
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Identification of a novel allosteric binding site in the CXCR2 chemokine receptor.
Journal: Molecular pharmacology 20111201
Title: The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
Journal: Journal of hepatology 20100501
Title: A common intracellular allosteric binding site for antagonists of the CXCR2 receptor.
Journal: British journal of pharmacology 20100401
Title: SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.
Journal: British journal of pharmacology 20090901
Title: Nicotinanilides as inhibitors of neutrophil chemotaxis.
Journal: Bioorganic & medicinal chemistry letters 20020603
Title: Auten RL, et al. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J Pharmacol Exp Ther. 2001 Oct;299(1):90-5.
Title: Milatovic S, et al. Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen. 2003 May-Jun;11(3):213-9.
Title: Li Yang, et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 2008 Jan;13(1):23-35.
